Dyslipidemia Clinical Trials in Busan
2 recruitingBusan, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 3
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Type 2 DiabetesDyslipidemia
CMG Pharmaceutical Co. Ltd240 enrolled24 locationsNCT06772168
Recruiting
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals1,500 enrolled4 locationsNCT06770543